Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?

Current Alzheimer Research - United Arab Emirates
doi 10.2174/156720511796717203
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Bentham Science Publishers Ltd.

Related search

Tau Amyloid Aggregates: The Choice of Pathways Makes the Difference

Biophysical Journal
Biophysics
2019English

New Targets for the Development of PET Tracers for Imaging Neurodegeneration in Alzheimer Disease

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2014English

The Disparate Effects of Two Molecular Chaperones on Tau Amyloid Formation

Biophysical Journal
Biophysics
2016English

Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates

Frontiers in Neuroscience
Neuroscience
2017English

Molecular PET Imaging for in Vivo Detection of Amyloid in the Human Brain

Clinical Neurology
Neurology
2009English

Clinical Validation of 18f-Azd4694, an Amyloid- -Specific PET Radioligand

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2012English

Total Aβ42/Aβ40 Ratio in Plasma Predicts Amyloid-Pet Status, Independent of Clinical AD Diagnosis

Neurology
Neurology
2020English

Amyloid-Β and Tau

JAMA Neurology
Neurology
2014English

A NH2 Tau Fragment Targets Neuronal Mitochondria at AD Synapses: Possible Implications for Neurodegeneration

Journal of Alzheimer's Disease
GerontologyClinical PsychologyMental HealthPsychiatryGeriatricsMedicineNeuroscience
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy